InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Aghazadeh Behzad, Director. Insider active across 2 companies, notably Aadi Bioscience, Inc.. Cumulatively, 5 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €31.8m. Activity tracked since 26 August 2021. The latest transaction was disclosed on 28 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Aghazadeh Behzad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
7,905 shares@ US$18.250.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000902664-26-003270:2
Canonical exit: 26 Oct 2026 (T+90)
2,333,333 shares@ US$15.0096.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000902664-26-003270:0
Canonical exit: 22 Oct 2026 (T+90)
50,000 shares@ US$22.313.1% of flowCommon Stock, par value $0.0001 per shareSEC:0000902664-26-003270:1
Canonical exit: 22 Oct 2026 (T+90)
1,260,000 shares@ US$12.5027.3% of flowCommon Stock, $0.0001 par value per share ("Common Stock")SEC:0000902664-22-004356:0
1,911,752 shares@ US$13.07757.1% of flowCommon Stock, $0.0001 par value per share ("Common Stock")SEC:0000902664-21-004071:0
5 of 5 declarations
About Aghazadeh Behzad
Behzad Aghazadeh serves as a Director at Aadi Bioscience, Inc. In this role, he participates in the governance of the company by contributing to strategic decision-making and performance oversight. With experience in the biopharmaceutical sector, Behzad provides valuable insights that help guide the company's initiatives. His commitment to innovation and research is fundamental to Aadi Bioscience's success.
